Primary Record
GADOVERSETAMIDE
Note: Only for scientific research or as raw materials for production.
- In stock
- 6,064 g
- Purity
- 99.6 %
- CAS
- 131069-91-5
Compound Identifiers & Properties
- CAS
- 131069-91-5
- PubChem CID
- 6435809
- SMILES
- COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
- Canonical SMILES
- COCCNC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-].[Gd+3]
Names & Synonyms
- GADOVERSETAMIDE
- Optimark
- UNII-RLM74T3Z9D
- Optimark In Plastic Container
- RLM74T3Z9D
- HSDB 7550
- Gadoversetamide [USAN:INN:BAN]
- DTXSID10156865
- GADOVERSETAMIDE (200 MG)
- Gadoversetamide [USAN:USP:INN:BAN]
- HY-A0196
- C20-H34-Gd-N5-O10
- CID6435809
- MP-1177
- LS-186531
- CS-0017542
- 131069-91-5
- (Gadoversetamide) (8,11-bis(carboxymethyl)-14-(2-((2-methoxyethyl)amino)-2-oxoethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)), gadolinium
- (N,N-Bis(2-((carboxymethyl)(((2-methoxyethyl)carbamoyl)methyl)amino)ethyl)glycinato(3-))gadolinium
- (8,11-bis(carboxymethyl)-14-(2-((2-methoxyethyl)amino)-2-oxoethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)), gadolinium
- {8,11-Bis[(carboxylato-kappaO)methyl]-14-{2-[(2-methoxyethyl)amino]-2-(oxo-kappaO)ethyl}-6-(oxo-kappaO)-2-oxa-5,8,11,14-tetraazahexadecan-16-oato-kappa~4~N~8~,N~11~,N~14~,O~16~}gadolinium
- Gadolinium, [6,9-bis[(carboxy-?O)methyl]-3-[2-[(2-methoxyethyl)amino]-2-(oxo-?O)ethyl]-11-(oxo-?O)-15-oxa-3,6,9,12-tetraazahexadecanoato(3-)-?N3,?N6,?N9,?O1]-; Gadolinium, [8,11-bis[(carboxy-?O)methyl]-14-[2-[(2-methoxyethyl)amino]-2-(oxo-?O)ethyl]-6-(oxo-?O)-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)-?N8,?N11,?N14,?O16]- (9CI); 2-Oxa-5,8,11,14-tetraazahexadecan-16-oic acid, 8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-, gadolinium complex; Gadolinium, [8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)]-; [6,9-Bis[(carboxy-?O)methyl]-3-[2-[(2-methoxyethyl)amino]-2-(oxo-?O)ethyl]-11-(oxo-?O)-15-oxa-3,6,9,12-tetraazahexadecanoato(3-)-?N3,?N6,?N9,?O1]gadolinium; Gadoversetamide; Gd-DTP-BMEA; MP 1177; OptiMARK; [N,N-Bis[2-[[(Carboxymethyl)[(2-methoxyethyl)carbamoyl]methyl]amino]ethyl]glycinato(3